Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI).
Canonica GW, Blasi F, Paggiaro P, Senna G, Passalacqua G, Spanevello A, Aliberti S, Bagnasco D, Bonavia M, Bonini M, Brussino L, Bucca C, Caiaffa MF, Calabrese C, Camiciottoli G, Caminati M, Carpagnano GE, Caruso C, Centanni S, Conte ME, Corsico AG, Cosmi L, Costantino MT, Crimi N, D'Alò S, D'Amato M, Del Giacco S, Farsi A, Favero E, Foschino Barbaro MP, Guarnieri G, Guida G, Latorre M, Lo Cicero S, Lombardi C, Macchia L, Mazza F, Menzella F, Milanese M, Montagni M, Montuschi P, Nucera E, Parente R, Patella V, Pelaia G, Pini L, Puggioni F, Ricciardi L, Ricciardolo FLM, Richeldi L, Ridolo E, Rolla G, Santus P, Scichilone N, Spadaro G, Vianello A, Viviano V, Yacoub MR, Zappa MC, Heffler E; SANI (Severe Asthma Network Italy). Canonica GW, et al. Among authors: caminati m. World Allergy Organ J. 2020 Sep 20;13(10):100464. doi: 10.1016/j.waojou.2020.100464. eCollection 2020 Oct. World Allergy Organ J. 2020. PMID: 32999699 Free PMC article. Review.
Italian study on buckwheat allergy: prevalence and clinical features of buckwheat-sensitized patients in Italy.
Badiu I, Olivieri E, Montagni M, Guida G, Mietta S, Pizzimenti S, Caminati M, Yacoub MR, Tombetti E, Preziosi D, Quecchia C, Minetti S, Facchetti S, Fassio F, Massaro I, Corradi L, Turi MC, Colagiovanni A, Pascolini L, Rossi FW, Losappio L, Sansone L, Imbesi S, Leto Barone S, Mistrello G, Heffler E. Badiu I, et al. Among authors: caminati m. Int J Immunopathol Pharmacol. 2013 Jul-Sep;26(3):801-6. doi: 10.1177/039463201302600328. Int J Immunopathol Pharmacol. 2013. PMID: 24067481 Free article.
Omalizumab management beyond clinical trials: the added value of a network model.
Caminati M, Senna G, Chieco Bianchi F, Marchi MR, Vianello A, Micheletto C, Pomari C, Tognella S, Savoia F, Mirisola V, Rossi A; NEONET Study Group. Caminati M, et al. Pulm Pharmacol Ther. 2014 Oct;29(1):74-9. doi: 10.1016/j.pupt.2014.01.007. Epub 2014 Feb 6. Pulm Pharmacol Ther. 2014. PMID: 24508951
Emerging drugs for allergic conjunctivitis.
Ridolo E, Montagni M, Caminati M, Senna G, Incorvaia C, Canonica GW. Ridolo E, et al. Among authors: caminati m. Expert Opin Emerg Drugs. 2014 Jun;19(2):291-302. doi: 10.1517/14728214.2014.902443. Epub 2014 Mar 25. Expert Opin Emerg Drugs. 2014. PMID: 24661261 Review.
188 results